Prothena | PRTA - Créanciers Commerciaux





Créanciers Commerciaux Changement Date
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Agios Pharmaceuticals USD 16.34M 2.6M 2026-06
Akebia Therapeutics USD 9.42M 1.04M 2026-06
ALKERMES USD 142.86M 40.5M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amgen USD 2.86B 16.65B 2026-06
Biogen USD 403.9M 45.4M 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
Exelixis USD 39.06M 14.91M 2026-06
Immunic USD 11.01M 873K 2026-03
Incyte USD 1.39B 1.16B 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
MacroGenics USD 3.44M 845K 2026-06
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
Prothena USD 1.94M 2.36M 2026-06
Regeneron Pharmaceuticals USD 1.16B 132.2M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
Vertex Pharmaceuticals USD 3.61B 135M 2026-06